BDBM752917 Synthesis of N-(2-(4,4-difluoropiperidin-1-yl)-6-methylpyrimidin-4-yl)-2-fluoro-4-((2-hydroxyethyl)sulfonamido)-6-((1S,6S)-6-methyl-3-azabicyclo[4.1.0]heptan-3-yl)benzamide (Example 31a) and N-(2-(4,4-difluoropiperidin-1-yl)-6-methylpyrimidin-4-yl)-2-fluoro-4-((2-hydroxyethyl)sulfonamido)-6-((1R,6R)-6-methyl-3-azabicyclo[4.1.0]heptan-3-yl)benzamide (Example 31b)::US20250197428, Example 31a

SMILES CCOC(=O)CS(=O)(=O)Nc1cc(F)c(C(=O)Oc2cc(C)nc(N3CCC(F)(F)CC3)n2)c(N2CC[C@]3(C)C[C@@H]3C2)c1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 752917   

TargetKinesin-like protein KIF18A(Human)
Accent Therapeutics

US Patent
LigandPNGBDBM752917(Synthesis of N-(2-(4,4-difluoropiperidin-1-yl)-6-m...)
Affinity DataIC50: 100nMAssay Description:A KIF18A ATPase assay was performed in small-volume, nonbinding, 384-well white plates at a final volume of 10 μL/well. Test compounds (10 mM solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/15/2025
Entry Details
US Patent